 |
|
The genomic landscape associated with resistance to aromatase inhibitors in breast cancer
Kirithika Sadasivam, Jeevitha Priya Manoharan, Hema Palanisamy, Subramanian Vidyalakshmi
Genomics Inform. 2023;21(2):e20 Published online 2023 Jun 30 DOI: https://doi.org/10.5808/gi.23012
|
|
Citations to this article as recorded by
 A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention
Yaping Yan, Tengkun Dai, Mengmeng Guo, Xu Zhao, Chao Chen, Ya Zhou, Ming Qin, Lin Xu, Juanjuan Zhao
International Journal of Biological Macromolecules.2024; 271: 132686. CrossRef Select gene mutations associated with survival outcomes in ER‐positive ERBB2‐negative early‐stage invasive breast cancer: A single‐institutional tissue bank study
Victor C. Kok, To‐Yu Huang, Yi‐Chiung Hsu, Yuan‐Ching Chang, Po‐Sheng Yang
Cancer Medicine.2024;[Epub] CrossRef
|